While the new therapy demonstrates promise in obesity reduction, individuals should recognize likely adverse reactions . Frequently reported concerns include gastrointestinal disturbances , such as nausea , vomiting , bowel issues, and infrequent bowel movements. Rarely occurring but significant issues may involve pancreatitis , hepatic issues, and